PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 273 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 3.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,652,769 | -11.5% | 347,222 | +17.6% | 0.06% | -10.3% |
| Q2 2023 | $12,040,339 | +0.1% | 295,345 | +0.2% | 0.07% | 0.0% |
| Q1 2023 | $12,029,808 | +72.0% | 294,776 | +62.7% | 0.07% | +65.9% |
| Q4 2022 | $6,994,587 | -35.4% | 181,160 | -11.0% | 0.04% | -39.7% |
| Q3 2022 | $10,823,000 | -18.6% | 203,522 | -10.7% | 0.07% | -12.8% |
| Q2 2022 | $13,289,000 | -31.1% | 227,969 | -9.8% | 0.08% | -17.9% |
| Q1 2022 | $19,288,000 | +61.2% | 252,733 | +27.1% | 0.10% | +66.7% |
| Q4 2021 | $11,963,000 | +7.2% | 198,837 | -0.2% | 0.06% | -1.7% |
| Q3 2021 | $11,157,000 | -8.9% | 199,265 | -1.3% | 0.06% | -7.9% |
| Q2 2021 | $12,244,000 | -13.7% | 201,804 | -0.3% | 0.06% | -18.2% |
| Q1 2021 | $14,193,000 | -7.5% | 202,498 | -21.0% | 0.08% | -8.3% |
| Q4 2020 | $15,343,000 | -7.7% | 256,413 | -7.3% | 0.08% | -16.0% |
| Q3 2020 | $16,622,000 | +44.6% | 276,485 | +26.2% | 0.10% | +42.9% |
| Q2 2020 | $11,495,000 | +10643.0% | 219,111 | +9164.7% | 0.07% | – |
| Q1 2020 | $107,000 | 0.0% | 2,365 | 0.0% | 0.00% | – |
| Q4 2019 | $107,000 | -73.3% | 2,365 | -77.6% | 0.00% | -100.0% |
| Q3 2019 | $401,000 | +420.8% | 10,552 | +488.8% | 0.00% | – |
| Q2 2019 | $77,000 | +13.2% | 1,792 | 0.0% | 0.00% | – |
| Q1 2019 | $68,000 | -11.7% | 1,792 | 0.0% | 0.00% | – |
| Q4 2018 | $77,000 | +1183.3% | 1,792 | +1135.9% | 0.00% | – |
| Q1 2018 | $6,000 | 0.0% | 145 | 0.0% | 0.00% | – |
| Q4 2017 | $6,000 | +200.0% | 145 | +83.5% | 0.00% | – |
| Q3 2017 | $2,000 | -89.5% | 79 | -86.8% | 0.00% | – |
| Q4 2016 | $19,000 | -24.0% | 600 | -18.4% | 0.00% | – |
| Q3 2016 | $25,000 | +78.6% | 735 | +75.0% | 0.00% | – |
| Q2 2016 | $14,000 | +40.0% | 420 | +121.1% | 0.00% | – |
| Q1 2016 | $10,000 | -97.9% | 190 | -98.9% | 0.00% | -100.0% |
| Q2 2013 | $480,000 | – | 16,556 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |